In breast cancer, lnc-BM increased JAK2 kinase activity to mediate oncostatin M- and IL-6-triggered STAT3 phosphorylation, promote ICAM1 and CCL2 expression, and mediate macrophage recruitment to the brain and consequently metastasis. Here, IL6 is linked to breast carcinoma.